Analyst Research

Report Title Price
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00
Provider: Wright Reports
$115.00
Provider: GlobalData
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Medistim receives clearance from Russia for sale of VeriQ C


Wednesday, 25 Jun 2014 06:21am EDT 

Medistim ASA:Receives clearance from health authorities in Russia for sale of its product VeriQ C.VeriQ C is intraoperative systems for quality assessment used during coronary artery bypass grafting (CABG).Medistim has already obtained clearance from Food and Drug Administration in United States (FDA), CE certificate in Europe and clearance for sale in Japan and Canada. 

Related Company News

Company Quote

22.8
-0.2 -0.87%
15 Sep 2014